688217 睿昂基因
按盤價 
18.370 +2.380 (+14.884%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.981 | 0.842 | 4.434 | 6.165 | 6.171 |
| 總資產報酬率 ROA (%) | 0.892 | 0.745 | 3.985 | 5.705 | 5.662 |
| 投入資產回報率 ROIC (%) | 0.944 | 0.813 | 4.323 | 6.019 | 6.057 | 邊際利潤分析 |
| 銷售毛利率 (%) | 75.113 | 73.211 | 60.800 | 73.108 | 71.843 |
| 營業利潤率 (%) | 2.232 | -2.513 | 16.901 | 12.529 | 14.061 |
| 息稅前利潤/營業總收入 (%) | 1.328 | -5.077 | 15.361 | 14.437 | 15.279 |
| 淨利潤/營業總收入 (%) | 4.308 | -1.861 | 15.536 | 13.775 | 13.624 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 156.098 | 1.691 | 124.449 | 66.951 | 90.921 |
| 價值變動淨收益/利潤總額(%) | 29.211 | -32.032 | 4.333 | 8.391 | 0.551 |
| 營業外收支淨額/利潤總額(%) | 6.567 | 30.983 | -0.323 | 14.116 | 0.059 | 償債能力分析 |
| 流動比率 (X) | 11.603 | 11.967 | 6.931 | 16.637 | 10.370 |
| 速動比率 (X) | 10.378 | 10.544 | 6.333 | 15.523 | 9.649 |
| 資產負債率 (%) | 7.004 | 7.325 | 10.375 | 5.368 | 7.015 |
| 帶息債務/全部投入資本 (%) | 2.130 | 2.272 | 0.533 | 0.224 | 0.822 |
| 股東權益/帶息債務 (%) | 4,527.806 | 4,222.674 | 18,236.108 | 43,618.024 | 11,831.649 |
| 股東權益/負債合計 (%) | 1,302.504 | 1,236.560 | 833.197 | 1,747.354 | 1,295.339 |
| 利息保障倍數 (X) | -1.251 | 3.534 | -10.337 | -95.100 | 12.639 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 259.507 | 308.851 | 177.977 | 202.927 | 206.701 |
| 存貨周轉天數 (天) | 303.120 | 298.236 | 98.723 | 147.966 | 142.071 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
